SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-14-001161
Filing Date
2014-06-04
Accepted
2014-06-03 18:33:47
Documents
10
Period of Report
2014-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e612380_8k-retrophin.htm 8-K 43942
2 e612380_ex10-1.htm EX-10.1 119968
3 e612380_ex10-2.htm EX-10.2 684762
4 e612380_ex10-3.htm EX-10.3 42922
5 GRAPHIC pic.jpg GRAPHIC 1949
6 GRAPHIC pic2.jpg GRAPHIC 2274
7 GRAPHIC pic3.jpg GRAPHIC 2356
8 GRAPHIC pic4.jpg GRAPHIC 2436
9 GRAPHIC pic5.jpg GRAPHIC 2089
10 GRAPHIC pic6.jpg GRAPHIC 2945
  Complete submission text file 0001193805-14-001161.txt   912990
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 14888922
SIC: 2834 Pharmaceutical Preparations